Analyst consensus rating
Genpact Analyst Rating: Buy
Direct answer
Genpact's consensus rating is Buy.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $42.91.
Forecast evidence checked October 27, 2026.
Get free Genpact email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $39.20
- Average price target
- $42.91
- High price target
- $58.00
- Low price target
- $36.00
- Low target gap
- -8.2%
- Target upside
- +9.5%
- High target gap
- +48%
- Target range width
- 56.1%
- Consensus rating
- Buy
- Analysts
- 11
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Genpact?
Genpact has a verified Buy consensus. The same dataset has an average price target of $42.91.
How far are Genpact's low and high targets from the recorded price?
The low target implies -8.2%, while the high target implies +48%.
How many analysts are included in Genpact's consensus?
The verified consensus includes 11 analysts.
How is Genpact's target upside or downside calculated?
The average target of $42.91 is divided by the recorded price of $39.20, then one is subtracted to produce +9.5%. This does not guarantee a future return.
When was Genpact's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.